Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,969 | -25,615 | -12,791 | -46,180 | -35,036 |
| Depreciation Amortization | -516 | -395 | -164 | 90 | 159 |
| Accounts receivable | N/A | N/A | -15,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,726 | -481 | 2,022 | -1,397 | -642 |
| Other Working Capital | 12,845 | 13,818 | 45 | 1,132 | 1,853 |
| Other Operating Activity | 1,848 | 2,876 | 14,098 | 4,672 | 3,721 |
| Operating Cash Flow | $-22,066 | $-9,797 | $-11,790 | $-41,683 | $-29,945 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 46,484 | 32,484 | 10,484 | 23,700 | 9,131 |
| PPE Investments | -7 | N/A | N/A | -8 | -8 |
| Investing Cash Flow | $46,477 | $32,484 | $10,484 | $23,692 | $9,123 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,216 | -811 | -405 | N/A | 0 |
| Common Stock Issued | 53,723 | 53,723 | 53,616 | 78 | 40 |
| Other Financing Activity | -2,815 | -2,815 | -2,682 | -319 | -317 |
| Financing Cash Flow | $49,692 | $50,097 | $50,529 | $-241 | $-277 |
| Beginning Cash Position | 24,732 | 24,732 | 24,732 | 42,964 | 42,964 |
| End Cash Position | 98,835 | 97,516 | 73,955 | 24,732 | 21,865 |
| Net Cash Flow | $74,103 | $72,784 | $49,223 | $-18,232 | $-21,099 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,066 | -9,797 | -11,790 | -41,683 | -29,945 |
| Capital Expenditure | -7 | N/A | N/A | -8 | -8 |
| Free Cash Flow | -22,073 | -9,797 | -11,790 | -41,691 | -29,953 |